Patients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors (RAASI's). Although these drugs protect the heart and kidney, a significant percentage of patients develop a dangerous side effect - high potassium levels in the blood (hyperkalemia).
Elevated potassium puts patients at risk of death from cardiac arrhythmias.
Subscribe to:
Post Comments (Atom)
Post a Comment